Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Alpa Laboratories Ltd Performance

Today's Low
88.20
arrowIcon
Today's High
92.95
52 Wk Low
55.00
arrowIcon
52 Wk High
115.00


Open

92

Traded Value (Cr)

25.91 L

Prev. Close

91

VWAP

89.53

Volume

24,633

Face Value

10

Alpa Laboratories Ltd Fundamentals

Market Cap
₹ 191 Cr
P/E Ratio (TTM)
10.68
P/B Ratio
1.34
Debt to Equity
0.01
ROE
12.97 %
EPS (TTM)
8.53
Dividend Yield
0.00%
Book Value
68.12

Click here to know more about Fundamentals

Alpa Laboratories Ltd Financials

Alpa Laboratories Ltd Financials

Alpa Laboratories Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 57.29 % 57.29 % 57.29 % 57.29 %
Retail 36.83 % 36.84 % 37.61 % 37.78 %
Others 5.37 % 4.91 % 4.99 % 4.92 %
FII 0.50 % 0.95 % 0.11 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

57.29%

Retail

36.83%

Others

5.37%

FII

0.50%

Mutual Funds

0.00%

Promoters

57.29%

Retail

36.84%

Others

4.91%

FII

0.95%

Mutual Funds

0.00%

Promoters

57.29%

Retail

37.61%

Others

4.99%

FII

0.11%

Mutual Funds

0.00%

Promoters

57.29%

Retail

37.78%

Others

4.92%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹91.97

PIVOT

resistance-arrow
Resistance
First Resistance₹94.233
Second Resistance₹96.617
Third Resistance₹98.883
support-arrow
Support
First Resistance₹89.583
Second Resistance₹87.317
Third Resistance₹84.933
RSI46.797
MACD0.440
ADX27.648
CCI-115.635

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day24,63313,23353.72
Week23,54213,80563.40
1 Month36,20323,91866.97
6 Months31,28918,62159.51

About Alpa Laboratories Ltd

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark 'Alpa' which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals. The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008. The Unit-II oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hi-potency formulations was made operational at Pithampur Industrial Area in 2012. The Company in FY 2014-15, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.

Managing Director

Paresh Chawla

Founded

1988

NSE Symbol

ALPA

Alpa Laboratories Ltd Management

NameDesignation
Mahendra Singh ChawlaChairman & Exec. Director
Pravin C ShahExecutive Director
Sharad Chand LunawatIndependent Director
Devendra BahetiIndependent Director
Krishna Das MalaniIndependent Director
Paresh ChawlaManaging Director
Jyoti JainIndependent Director
Swati BaghCompany Sec. & Compli. Officer
Vitthal KothanaExecutive Director
SUNIL VALECHAAdditional Director
Saket BahetiIndependent Director
Pratibha LunawatIndependent Director

Alpa Laboratories Ltd News

Alpa Laboratories to hold board meeting
On 28 May 2024
Alpa Laboratories consolidated net profit declines 11.91% in the December 2023 quarter
Sales reported at Rs 27.31 crore
Alpa Laboratories schedules board meeting
On 13 February 2024
Alpa Laboratories consolidated net profit rises 2795.00% in the September 2023 quarter
Sales rise 139.22% to Rs 32.39 crore
Alpa Laboratories to declare Quarterly Result
On 7 November 2023
Alpa Laboratories to conduct AGM
On 29 September 2023
Alpa Laboratories consolidated net profit rises 12.22% in the June 2023 quarter
Sales rise 13.43% to Rs 25.43 crore
Alpa Laboratories to hold board meeting
On 14 August 2023
Alpa Laboratories reports consolidated net profit of Rs 4.65 crore in the March 2023 quarter
Sales rise 15.90% to Rs 29.16 crore
Alpa Laboratories to conduct board meeting
On 29 May 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,616 Cr
₹ 1,494.65
(-1.78 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.87 %)
33.36
DIVISLAB₹ 1,00,611 Cr
₹ 3,789.95
(-3.50 %)
73.75
DRREDDY₹ 98,044 Cr
₹ 5,877.35
(-2.96 %)
22.59
ZYDUSLIFE₹ 97,423 Cr
₹ 968.20
(-3.72 %)
36.23

Alpa Laboratories Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Alpa Laboratories Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Alpa Laboratories Ltd's share price is ₹88.55 as of May 9, 2024

Alpa Laboratories Ltd's P/E ratio is 10.68 times as of May 9, 2024.

Alpa Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 1.34, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Alpa Laboratories Ltd's market is 192 Cr as on May 9, 2024.

The current financial records of Alpa Laboratories Ltd show a 12.97% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Alpa Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Alpa Laboratories Ltd's 52-week high and low as of May 9, 2024 are ₹92.95 and ₹88.2 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Alpa Laboratories Ltd stands at 57.29%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 0.95% to 0.50%.